However, establishing a formal Health Technology Assessment system would help determine which pharmaceuticals should be covered. Several of these challenges have been present since the very inception of the system in the early 1990s. However, there is no overarching political vision that political parties across the spectrum (and different stakeholders in the health system) can subscribe to.